Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan
· Delayed Price · Currency is TWD 25.60
-1.40 (-5.19%)
At close: Mar 9, 2026
Formosa Pharmaceuticals Revenue
Formosa Pharmaceuticals had revenue of 911.00K TWD in the quarter ending September 30, 2025, a decrease of -78.98%. This brings the company's revenue in the last twelve months to 12.16M, down -91.15% year-over-year. In the year 2024, Formosa Pharmaceuticals had annual revenue of 143.36M with 359.89% growth.
Revenue (ttm)
12.16M
Revenue Growth
-91.15%
P/S Ratio
317.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.87B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Energenesis Biomedical CO.,LTD. | 7.46M |
| Medigen Biotechnology | 1.59B |
| Genovate Biotechnology | 492.41M |
| ACRO Biomedical | 36.50M |
| BioGend Therapeutics | 222.34M |
| Senhwa Biosciences | 1.08M |
| Sagittarius Life Science | 424.44M |
| BRIM Biotechnology | 3.17M |